title: Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux.
authors.forename: J
authors.initials: J
authors.lastname: Bordes
authors.forename: Y
authors.initials: Y
authors.lastname: Asencio
authors.forename: N
authors.initials: N
authors.lastname: Kenane
authors.forename: J
authors.initials: J
authors.lastname: Fesselet
authors.forename: E
authors.initials: E
authors.lastname: Meaudre
authors.forename: P
authors.initials: P
authors.lastname: Goutorbe
mesh_terms: D000208:Acute Disease; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D003029:Coagulants / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use*; D000077425:Fondaparinux; D020199:Hematoma, Subdural, Acute / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011134:Polysaccharides / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000627:therapeutic use; D020521:Stroke / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D003029:Coagulants; D011134:Polysaccharides; D011994:Recombinant Proteins; D015942:Factor VIIa; D000077425:Fondaparinux